173 related articles for article (PubMed ID: 30408813)
1. Gout in Aotearoa New Zealand: the equity crisis continues in plain sight.
Dalbeth N; Dowell T; Gerard C; Gow P; Jackson G; Shuker C; Te Karu L
N Z Med J; 2018 Nov; 131(1485):8-12. PubMed ID: 30408813
[No Abstract] [Full Text] [Related]
2. Gout in Aotearoa New Zealand: are we going to ignore this for another 3 years?
Dalbeth N; Gow P; Jackson G; Shuker C; Te Karu L; Gerard C; Winnard D
N Z Med J; 2016 Jan; 129(1429):10-3. PubMed ID: 26914294
[No Abstract] [Full Text] [Related]
3. National prevalence of gout derived from administrative health data in Aotearoa New Zealand.
Winnard D; Wright C; Taylor WJ; Jackson G; Te Karu L; Gow PJ; Arroll B; Thornley S; Gribben B; Dalbeth N
Rheumatology (Oxford); 2012 May; 51(5):901-9. PubMed ID: 22253023
[TBL] [Abstract][Full Text] [Related]
4. Facilitating equitable prevention and management of gout for Māori in Northland, New Zealand, through a collaborative primary care approach.
Lawrence A; Scott S; Saparelli F; Greville G; Miller A; Taylor A; Gow P
J Prim Health Care; 2019 Jul; 11(2):117-127. PubMed ID: 32171354
[TBL] [Abstract][Full Text] [Related]
5. Variation in gout care in Aotearoa New Zealand: a national analysis of quality markers.
Jackson G; Dalbeth N; Te Karu L; Winnard D; Gow P; Gerard C; Minko N
N Z Med J; 2014 Oct; 127(1404):37-47. PubMed ID: 25331310
[TBL] [Abstract][Full Text] [Related]
6. Gender and Ethnic Inequities in Gout Burden and Management.
Guillén AG; Te Karu L; Singh JA; Dalbeth N
Rheum Dis Clin North Am; 2020 Nov; 46(4):693-703. PubMed ID: 32981646
[TBL] [Abstract][Full Text] [Related]
7. Quality of care in people requiring hospital admission for gout in Aotearoa New Zealand: a nationwide analysis.
Murdoch R; Jones P; Greenwell J; Dalbeth N
Intern Med J; 2022 Dec; 52(12):2136-2142. PubMed ID: 34339089
[TBL] [Abstract][Full Text] [Related]
8. Prescription and comorbidity screening following consultation for acute gout in primary care.
Roddy E; Mallen CD; Hider SL; Jordan KP
Rheumatology (Oxford); 2010 Jan; 49(1):105-11. PubMed ID: 19920095
[TBL] [Abstract][Full Text] [Related]
9. Prevention of colchicine toxicity in patients with gout.
Dalbeth N; Gow P
N Z Med J; 2007 Apr; 120(1252):U2503. PubMed ID: 17460750
[No Abstract] [Full Text] [Related]
10. Potential unmet need for gout diagnosis and treatment: capture-recapture analysis of a national administrative dataset.
Jackson G; Wright C; Thornley S; Taylor WJ; Te Karu L; Gow PJ; Arroll B; Gribben B; Dalbeth N; Winnard D
Rheumatology (Oxford); 2012 Oct; 51(10):1820-4. PubMed ID: 22723595
[TBL] [Abstract][Full Text] [Related]
11. [Acute treatment of gout].
Lund-Olesen K
Ugeskr Laeger; 1998 Mar; 160(10):1498. PubMed ID: 9520623
[No Abstract] [Full Text] [Related]
12. Improving gout education from patients' perspectives: a focus group study of Māori and Pākehā people with gout.
Rolston CJ; Conner TS; Stamp LK; Neha T; Pitama S; Fanning N; Janes R; Judd A; Hudson B; Hegarty RM; Treharne GJ
J Prim Health Care; 2018 Oct; 10(3):194-200. PubMed ID: 31039932
[TBL] [Abstract][Full Text] [Related]
13. Stopping progression to tophaceous gout. When and how to use urate-lowering therapy.
McDonald E; Marino C
Postgrad Med; 1998 Dec; 104(6):117-20, 123-4, 127. PubMed ID: 9861261
[TBL] [Abstract][Full Text] [Related]
14. Contraindications to pharmacologic therapies for gout.
Lewis DA; Herrington WG
Am J Med; 2011 Oct; 124(10):e15. PubMed ID: 21962322
[No Abstract] [Full Text] [Related]
15. Steroid for gout: myth or elixir?
Chao CT
Am J Med; 2011 Oct; 124(10):e17; author reply e19. PubMed ID: 21962323
[No Abstract] [Full Text] [Related]
16. [Hyperuricemia and gout--treatment].
Gröbner W; Walter-Sack I
Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
[No Abstract] [Full Text] [Related]
17. Pounamu: Achieving health equity in Aotearoa New Zealand: the contribution of medicines optimisation.
Te Karu L; Bryant L; Harwood M; Arroll B
J Prim Health Care; 2018 Mar; 10(1):11-15. PubMed ID: 30068445
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of contraindications and prescription of pharmacologic therapies for gout.
Keenan RT; O'Brien WR; Lee KH; Crittenden DB; Fisher MC; Goldfarb DS; Krasnokutsky S; Oh C; Pillinger MH
Am J Med; 2011 Feb; 124(2):155-63. PubMed ID: 21295195
[TBL] [Abstract][Full Text] [Related]
19. [Gout as a cause of uveitis].
Trapkowski A; Glasner L; Iwaszkiewicz-Bilikiewiczowa B
Klin Oczna; 1997; 99(4):269-70. PubMed ID: 9577121
[TBL] [Abstract][Full Text] [Related]
20. [Hyperuricemia and gout. Case report].
Gröbner W; Walter-Sack I
Dtsch Med Wochenschr; 2002 Feb; 127(5):207-9. PubMed ID: 11821992
[No Abstract] [Full Text] [Related]
[Next] [New Search]
